Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chouza

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neural Transmission. Supplementum|October 5, 2006
Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associationsC Chouza, R Buzó, A Scaramelli, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Combination of selegiline and controlled release levodopa in the treatment of fluctuations of clinical disability in parkinsonian patientsC Chouza, R Aljanati, A Scaramelli, et al.
Advances in Neurology|January 1, 1990
Long-term treatment with Madopar HBS in parkinsonians with fluctuationsC Chouza, R Aljanati, J L Caamaño, et al.
Drugs|March 4, 1998
Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study GroupU K Rinne, F Bracco, C Chouza, et al.
Advances in Neurology|January 1, 1984
Hemi-parkinsonism: clinical, neuropsychological, and tomographical studiesC Chouza, S Romero, G Laguardia, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 25, 1982
[Clinical trial of tiapride in patients with dyskinesia (author's transl)]C Chouza, S Romero, J Lorenzo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1984
Familial spastic ataxia associated with Ehlers-Danlos syndrome with platelet dysfunctionC Chouza, J L Caamaño, O De Medina, et al.
Neurology|February 1, 1997
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study GroupU K Rinne, F Bracco, C Chouza, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neural Transmission. Supplementum|October 5, 2006
Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associationsC Chouza, R Buzó, A Scaramelli, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Combination of selegiline and controlled release levodopa in the treatment of fluctuations of clinical disability in parkinsonian patientsC Chouza, R Aljanati, A Scaramelli, et al.
Advances in Neurology|January 1, 1990
Long-term treatment with Madopar HBS in parkinsonians with fluctuationsC Chouza, R Aljanati, J L Caamaño, et al.
Drugs|March 4, 1998
Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study GroupU K Rinne, F Bracco, C Chouza, et al.
Advances in Neurology|January 1, 1984
Hemi-parkinsonism: clinical, neuropsychological, and tomographical studiesC Chouza, S Romero, G Laguardia, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 25, 1982
[Clinical trial of tiapride in patients with dyskinesia (author's transl)]C Chouza, S Romero, J Lorenzo, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1984
Familial spastic ataxia associated with Ehlers-Danlos syndrome with platelet dysfunctionC Chouza, J L Caamaño, O De Medina, et al.
Neurology|February 1, 1997
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study GroupU K Rinne, F Bracco, C Chouza, et al.
Pageof 3